** Shares in Elekta EKTAb.ST rise 2.8% after the radiation
therapy equipment maker beat Q1 sales and margin expectations as
improving trend from the previous quarters continues
** It delivered Q1 revenue of SEK 3,828 million, 3% ahead of
consensus of SEK 3,714 million
** It said Q1 gross margin was 41.5%, above 37.8% seen by
consensus
** Elekta said it expects the significant improvement seen
during the last three quarters to continue into next quarter
** Jefferies says the company delivered strong sales/margin
in the quarter helped by the conversion of its strong backlog
** Bernstein points out that the company's gross margin is
back to pre-COVID levels, positively impacted by revenue growth,
lower logistics costs, and cost-reductions
(Reporting by Marta Frackowiak)
((marta.frackowiak@thomsonreuters.com))